Differential importance of glucose-dependent insulinotropic polypeptide vs glucagon-like peptide 1 receptor signaling for beta cell survival in mice
At the molecular level, preclinical models have suggested a multimodal mechanism
The pen does the rest
I believe that one reason GLP-1 is the Swiss Army knife of metabolism that it can do so many different things in so many different organs is its ability to reduce inflammation. Exactly how that happens, however, is still shrouded in mystery, Drucker says
Key Takeaways Tirzepatide can cause nausea by slowing gastric emptying, making large or heavy meals more likely to trigger symptoms
Unlike older GLP-1 medications that target only one hormone, tirzepatide is the first dual GLP-1 (glucagon-like peptide 1) and GIP receptor agonist that offers greater benefits, including stronger appetite suppression, deeper metabolic changes, and more significant weight loss